Related Experiment Video

Updated: Aug 19, 2026

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure
07:41

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure

Published on: February 8, 2022

Balloon dilatation of pulmonary valve in Tetralogy of Fallot's

Vikas Kohli1

  • 1Department of Cardiology, Indraprastha Apollo Hospital, Sarita Vihar, New Delhi, India. vkohli_md@yahoo.com

Indian Journal of Pediatrics
|March 11, 2005
PubMed

Insights

Balloon dilatation of the pulmonary valve is a viable alternative to palliative Blalock-Taussing shunt surgery for infants with Tetralogy of Fallot (TOF). This intervention improves pulmonary artery size and reduces the need for further palliative procedures.

Area of Science:

  • Pediatric Cardiology
  • Interventional Cardiology
  • Congenital Heart Disease

Background:

  • Tetralogy of Fallot (TOF) is a congenital heart defect often requiring surgical palliation.
  • The Blalock-Taussing (BT) shunt has been a common palliative approach for TOF with progressive cyanosis.
  • Limited data exists on advanced interventional procedures for TOF in India.

Observation:

  • This report details a successful case of pulmonary valve balloon dilatation in an infant with TOF.
  • Literature review identified 12 studies involving 332 TOF patients who underwent pulmonary valve balloon dilatation.
  • This interventional approach was explored as an alternative to BT shunt surgery.

Findings:

  • Pulmonary valve balloon dilatation in TOF patients led to a significant increase in pulmonary artery Z-score.
  • The incidence of conversion to BT shunt surgery after balloon dilatation was low.
  • This interventional strategy demonstrated favorable outcomes in selected TOF cases.

Implications:

  • Pulmonary valve balloon dilatation should be considered as a primary interventional option for selected TOF patients.
  • This approach may help transition palliative surgical management to a less invasive interventional procedure.
  • Further research can establish this intervention as a standard of care in managing TOF.

More Related Videos

Four-Dimensional Computed Tomography-Guided Valve Sizing for Transcatheter Pulmonary Valve Replacement09:57

Four-Dimensional Computed Tomography-Guided Valve Sizing for Transcatheter Pulmonary Valve Replacement

Published on: January 20, 2022

Related Concept Videos

Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
Pneumothorax II: Pathophysiology01:08

Pneumothorax II: Pathophysiology

Pneumothorax means the presence of air in the pleural space — the thin potential gap between the visceral and parietal pleura. This condition disrupts the normal pressure balance that keeps the lungs inflated, leading to partial or complete collapse of the affected lung.Normal physiologyUnder normal conditions, the pleural space maintains a slightly negative intrapleural pressure, which keeps the lungs expanded against the chest wall. This negative pressure creates a delicate balance between...